| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Hozumi Motohashi
|
|||||||
| GSE181641 |
Oxygen-dependent changes of gene expression in BMDM after LPS treatment
|
36 | Hozumi Motohashi | Apr 06, 2024 | ||||
| GSE181642 |
Lysosome activity-dependent changes of gene expression in BMDM after LPS treatment
|
36 | Hozumi Motohashi | Apr 06, 2024 | ||||
| GSE181643 |
Oxygen-dependent changes and lysosome activity-dependent changes of gene expression in BMDM after LPS treatment
|
72 | Hozumi Motohashi | Apr 06, 2024 | ||||
| GSE211951 |
Pulmonary gene expression after ischemia reperfusion in young and old mice
|
24 | Hozumi Motohashi | Apr 06, 2024 | ||||
| GSE186186 |
CEBPB-dependent enhancer formation in NRF2-activated non-small cell lung cancer cell line A549 [ChIP-seq]
|
8 | Hozumi Motohashi | Oct 08, 2022 | ||||
| GSE186187 |
CEBPB-dependent transcriptome in NRF2-activated non-small cell lung cancer cell line A549 [RNA-seq]
|
4 | Hozumi Motohashi | Oct 08, 2022 | ||||
| GSE118840 |
Contribution of NRF2 to genome-wide distribution of H3K27ac deposition in A549 cells, a non-small cell lung cancer cell line with KEAP1 mutation
|
8 | Hozumi Motohashi | Sep 23, 2020 | ||||
| GSE118841 |
Description of NRF2-dependent transcriptome in non-small cell lung cancer cell lines with KEAP1 mutations
|
12 | Hozumi Motohashi | Sep 23, 2020 | ||||
| GSE118842 |
Description of transcriptome in non-small cell lung cancer cell lines without KEAP1/NRF2 mutations in response to an electrophilic reagent dimethylmaleate (DEM)
|
8 | Hozumi Motohashi | Sep 23, 2020 | ||||
| GSE118844 |
NRF2-dependent transcriptome and H3K27ac distribution in non-small cell lung cancer
|
28 | Hozumi Motohashi | Sep 23, 2020 | ||||
| GSE98594 |
Gene expression analysis of WT and Keap1–/– MEFs in vitro culture condition (2D) and in allograft condition (3D)
|
8 | Hozumi Motohashi | May 06, 2017 |
